Skip to main content

Table 2 Weights assigned to outcomes included in the benefit-harm analyses of low dose aspirin for primary prevention of cardiovascular disease and colorectal cancer

From: Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer

Outcome

5-year survival

Weight

Myocardial infarction [34]

79.2 %

0.5

Ischemic stroke [35]

42.0 %

1.0

Hemorrhagic stroke [35]

42.0 %

1.0

Gastrointestinal bleeds [36]

45.5 % (3-year)

1.0

Colorectal cancer [37]

65.2 %

0.5

Biliary cancer [37]

18.3 %

1.0

Esophageal cancer [37]

18.3 %

1.0

Gastric cancer [37]

30.3 %

1.0

Breast cancer [37]

89.6 %

0.5

Lung cancer [37]

18.0 %

1.0

Prostate cancer [37]

98.9 %

0.1

Hematological cancer [37]

48.5 –85.8 %

0.5

Pancreatic cancer [37]

7.9 %

1.0

Bladder cancer [37]

77.4 %

0.5

Gynecological cancer [37]

45.8 –81.6 %

0.5

Renal cancer [37]

73.6 %

0.5

  1. These weights can be adjusted individually on [http://www.benefit-harm-balance.com]
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us